Review of the recruitment process for a large investigator-initiated trial in early Parkinson ’s disease
We describe the organization of the Levodopa in the Early Parkinson ’s disease (LEAP) trial and the results of an external assessment of the recruitment process.MethodsSeveral strategies were used to ensure that recruitment for the trial was effective and efficient. We analyzed the patterns in referrals, inclusions, and non-inclusions to investigate whether there were bottlenecks in the referral and inclusion process. For the external assessment of the recruitment process, the QuinteT Recruitment Intervention (QRI-Two) was used retrospectively, focusing on finding possible issues impeding recruitment that are less easily...
Source: Trials - February 14, 2022 Category: Research Source Type: clinical trials
Randomized Study of Efficacy of Different Treatment Regimens of Olokizumab
Condition: COVID-19 Interventions: Drug: Olokizumab; Drug: Standard therapy Sponsors: R-Pharm; Federal Budget Institution of Science " Central Research Institute of Epidemiology " of the Rospotrebnadzor; Group of companies Medsi, JSС Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2022 Category: Research Source Type: clinical trials
